| Developing competitive and sustainable Polish generic medicines market. | |
| | |
MedLine Citation:
|
PMID: 19839067 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIM: To descriptively analyze the policy environment surrounding the Polish generic medicines retail market. METHOD: The policy analysis was based on an international literature review. Also, a simulation exercise was carried out to compute potential savings from substituting generic for originator medicines in Poland using IMS Health pharmaceutical intelligence data. RESULTS: Poland has a mature, high-volume, low-value generic medicines market, primarily driven by the establishment of the reference price at the price of the cheapest medicine in combination with pricing regulation and the low level of medicine prices. The practice of discounting in the distribution chain implies that the National Health Fund and patients do not capture the potential savings from a generic medicines market where companies compete on price. This high-volume market has benefited in the past from the limited availability of originator medicines and a short data exclusivity period, even though there are no incentives for physicians to prescribe generic medicines and a financial disincentive for pharmacists to dispense generic medicines. Increased generic substitution would be expected to reduce public expenditure on originator medicines by 21%. CONCLUSION: To develop a competitive and sustainable market, Poland needs to consider moving away from competition by discount to competition by price. This could be achieved by replacing maximum distribution margins by fixed margins. Also, Poland may wish to raise reference prices as a temporary measure to boost market entry for medicine classes with few generic medicines. |
| | |
Authors:
|
Steven Simoens |
Related Documents
:
|
3034827 - Essentials of a rubidium-82 generator for nuclear medicine. 22468757 - Medicinal chemistry of a3 adenosine receptor modulators: pharmacological activities and... 3350167 - Survey of attitudes regarding the use of siblings for gamete donation. 18442607 - Thoracoscopic total parietal pleurectomy for primary spontaneous pneumothorax. 6808837 - Model for cost-benefit analysis of clinical pharmacy in family practice. 10290697 - Hospitals can improve cash flow by managing preauthorizations. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Croatian medical journal Volume: 50 ISSN: 1332-8166 ISO Abbreviation: Croat. Med. J. Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2009-10-19 Completed Date: 2010-01-13 Revised Date: 2010-09-28 |
Medline Journal Info:
|
Nlm Unique ID: 9424324 Medline TA: Croat Med J Country: Croatia |
Other Details:
|
Languages: eng Pagination: 440-8 Citation Subset: IM |
Affiliation:
|
Research Centre for Pharmaceutical Care and Pharmaco-economics, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Onderwijs en Navorsing, 3000 Leuven, Belgium. steven.simoens@pharm.kuleuven.be |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Computer Simulation Cost Control Drug Costs* Drug Industry / economics* Drugs, Generic / economics* Economic Competition* Health Policy* Humans Poland Reimbursement Mechanisms Reimbursement, Incentive |
| Chemical | |
Reg. No./Substance:
|
0/Drugs, Generic |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Reference pricing system and competition: case study from portugal.
Next Document: B-type Natriuretic Peptide as Predictor of Heart Failure in Patients with Acute ST Elevation Myocard...